DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
MLN1202 is an investigational drug.
There have been 7 clinical trials for MLN1202. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2005.
The most common disease conditions in clinical trials are Cardiovascular Diseases, Atherosclerosis, and Multiple Sclerosis. The leading clinical trial sponsors are Takeda, Millennium Pharmaceuticals, Inc., and Southwest Oncology Group.
Recent Clinical Trials for MLN1202
|Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Investigational Treatments in Combination With Standard of Care Immune Checkpoint Inhibitors in Participants With Advanced Melanoma||Millennium Pharmaceuticals, Inc.||Phase 1|
|Proof of Mechanism Study of MLN1202 on Atherosclerotic Inflammation in Participants With Stable Atherosclerotic Cardiovascular Disease||Takeda||Phase 2|
|Efficacy and Safety of Weekly Subcutaneous MLN1202 in Improving Diabetic Nephropathy in Participants With Macroalbuminuria||Takeda||Phase 2|